Clinical Trials Browser

Phase 2 × Metastatic Small Intestinal Adenocarcinoma × Taxes × Clear all

NCT04205968 2025-11-05

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Phase 2 Recruiting

Metastatic Small Intestinal Adenocarcinoma